Linked Life Data

2214780

Source:http://linkedlifedata.com/resource/pubmed/id/2214780

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2214780rdf:typepubmed:Citationlld:pubmed
pubmed-article:2214780lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2214780lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:2214780lifeskim:mentionsumls-concept:C1721101lld:lifeskim
pubmed-article:2214780lifeskim:mentionsumls-concept:C0005390lld:lifeskim
pubmed-article:2214780lifeskim:mentionsumls-concept:C0008024lld:lifeskim
pubmed-article:2214780lifeskim:mentionsumls-concept:C0021212lld:lifeskim
pubmed-article:2214780lifeskim:mentionsumls-concept:C1709634lld:lifeskim
pubmed-article:2214780pubmed:issue6lld:pubmed
pubmed-article:2214780pubmed:dateCreated1990-11-6lld:pubmed
pubmed-article:2214780pubmed:abstractTextThe plasma concentrations of 3 beta-hydroxy-5-cholestenoic acid, 3 beta,7 alpha-dihydroxy-5-cholestenoic acid and 7 alpha-hydroxy-3-oxo-4-cholestenoic acid have been compared with that of 7 alpha-hydroxy-4-cholesten-3-one in healthy subjects and in patients with an expected decrease or increase of the bile acid production. In controls and patients with liver disease, the level of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid was positively correlated to that of 3 beta,7 alpha-dihydroxy-5-cholestenoic acid and not to that of 7 alpha-hydroxy-4-cholesten-3-one. In patients with stimulated bile acid formation the levels of the acids were not correlated to each other but there was a significant positive correlation between the levels of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid and 7 alpha-hydroxy-4-cholesten-3-one. These findings indicate that the precursor of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid differs depending on the activity of cholesterol 7 alpha-hydroxylase. Since the activity of this enzyme is reflected by the level of 7 alpha-hydroxy-4-cholesten-3-one in plasma the findings are compatible with a formation of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid from 3 beta,7 alpha-dihydroxy-5-cholestenoic acid when the rate of bile acid formation is normal or reduced and from 7 alpha-hydroxy-4-cholesten-3-one under conditions of increased bile acid synthesis. In support of this interpretation, 7 alpha,26-dihydroxy-4-cholesten-3-one was identified at elevated levels in plasma from patients with ileal resection or treated with cholestyramine. The levels of 7 alpha,12 alpha-dihydroxy-4-cholesten-3-one were also higher than normal in these patients. Based on these findings and previous knowledge, a model is proposed for the biosynthesis of bile acids in man. Under normal conditions, two major pathways, one "neutral" and one "acidic" or "26-oxygenated", lead to the formation of cholic acid and chenodeoxycholic acid, respectively. These pathways are separately regulated. When the activity of cholesterol 7 alpha-hydroxylase is high, the "neutral" pathway is most important whereas the reverse is true when cholesterol 7 alpha-hydroxylase activity is low. In cases with enhanced activity of cholesterol 7 alpha-hydroxylase, the "neutral" pathway is connected to the "acidic" pathway via 7 alpha,26-dihydroxy-4-cholesten-3-one, whereas a flow from the acidic pathway to cholic acid appears to be of minor importance.lld:pubmed
pubmed-article:2214780pubmed:languageenglld:pubmed
pubmed-article:2214780pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2214780pubmed:citationSubsetIMlld:pubmed
pubmed-article:2214780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2214780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2214780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2214780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2214780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2214780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2214780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2214780pubmed:statusMEDLINElld:pubmed
pubmed-article:2214780pubmed:monthAuglld:pubmed
pubmed-article:2214780pubmed:issn0022-4731lld:pubmed
pubmed-article:2214780pubmed:authorpubmed-author:SjövallJJlld:pubmed
pubmed-article:2214780pubmed:authorpubmed-author:AxelsonMMlld:pubmed
pubmed-article:2214780pubmed:issnTypePrintlld:pubmed
pubmed-article:2214780pubmed:day28lld:pubmed
pubmed-article:2214780pubmed:volume36lld:pubmed
pubmed-article:2214780pubmed:ownerNLMlld:pubmed
pubmed-article:2214780pubmed:authorsCompleteYlld:pubmed
pubmed-article:2214780pubmed:pagination631-40lld:pubmed
pubmed-article:2214780pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:meshHeadingpubmed-meshheading:2214780-...lld:pubmed
pubmed-article:2214780pubmed:year1990lld:pubmed
pubmed-article:2214780pubmed:articleTitlePotential bile acid precursors in plasma--possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man.lld:pubmed
pubmed-article:2214780pubmed:affiliationDepartment of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden.lld:pubmed
pubmed-article:2214780pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2214780pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2214780lld:pubmed